[Elsevier] Effect of dapagliflozin-spironolactone combination therapy versus monotherapy on albuminuria reduction and hyperkalemia risk in elderly patients with early type 2 diabetic nephropathy receiving high-dose RASi: A randomized controlled trial

fca1709 Post time The day before yesterday 10:18 | Show all posts |Read mode
This post will be closed automatically in 2026-07-29 10:18
Reward10points

journalㄩThe American Journal of the Medical Sciences

AuthorsㄩYingying Chen; Peng Liu; Lili Chen; Fengmei Zhang

Published dateㄩ2026-8-

DOIㄩ10.1016/j.amjms.2026.05.005

PDF linkㄩhttps://www.sciencedirect.com/sc ... 002962926001874/pdf

Article linkㄩhttps://doi.org/10.1016/j.amjms.2026.05.005

Article SourceㄩElsevier BV


Remarkㄩ
Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Senior Member
  • post

  • reply

  • points

    770


Return to the list